Alnylam Pharmaceuticals
ALNY
#638
Rank
A$49.26 B
Marketcap
$380.56
Share price
-0.51%
Change (1 day)
69.94%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company